What is the recommended dosage of cefdinir (Cefdinir) for a patient with Group A Streptococcal (GAS) pharyngitis, considering age and renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Group A Streptococcal Pharyngitis

Critical Context: Cefdinir is NOT a First-Line Agent

Cefdinir should only be used for GAS pharyngitis in patients with non-immediate (non-anaphylactic) penicillin allergy who cannot tolerate first-generation cephalosporins like cephalexin or cefadroxil. 1, 2 Penicillin or amoxicillin remains the drug of choice for all non-allergic patients due to proven efficacy, narrow spectrum, safety, and low cost. 1, 2

Specific Dosing Regimens When Cefdinir is Appropriate

Pediatric Patients (6 months to 12 years)

  • 14 mg/kg once daily (maximum 600 mg) for 10 days 3, 4, 5
  • Alternative: 7 mg/kg twice daily (maximum 300 mg per dose) for 10 days 4, 5
  • Both regimens demonstrate equivalent efficacy with 92-94% clinical cure rates 4, 5

Adolescents and Adults (≥13 years)

  • 600 mg once daily for 10 days 3, 4
  • Alternative: 300 mg twice daily for 10 days 3, 4
  • Both regimens achieve 91-95% clinical cure rates and 91-92% bacterial eradication rates 3, 4

Why First-Generation Cephalosporins are Preferred Over Cefdinir

For non-anaphylactic penicillin allergy, first-generation cephalosporins (cephalexin 20 mg/kg twice daily or cefadroxil 30 mg/kg once daily) are strongly preferred over cefdinir due to:

  • Stronger evidence quality (strong, high-quality vs. moderate-quality for cefdinir) 1, 2
  • Narrower spectrum of activity, reducing selection pressure for resistant organisms 6
  • Lower cost 1, 2
  • Essentially zero resistance rates among GAS 6

Critical Treatment Duration Requirement

A full 10-day course is absolutely essential to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever. 1, 2, 6 Shortening the course by even a few days dramatically increases treatment failure rates and rheumatic fever risk. 2, 6 This applies to all antibiotics except azithromycin, which requires only 5 days due to its unique pharmacokinetics. 1, 2

When Cefdinir Should NOT Be Used

Immediate/Anaphylactic Penicillin Allergy

Avoid cefdinir (and all beta-lactams) in patients with immediate hypersensitivity reactions including anaphylaxis, angioedema, respiratory distress, or urticaria occurring within 1 hour of penicillin administration. 2, 6 Up to 10% cross-reactivity exists between penicillin and all cephalosporins in this population. 1, 2, 6

For these patients, use:

  • Clindamycin 7 mg/kg three times daily (maximum 300 mg/dose) for 10 days - preferred due to only 1% resistance rate 1, 2, 6
  • Azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days - acceptable alternative but 5-8% macrolide resistance in US 1, 2

As First-Line Therapy

Never prescribe cefdinir as first-line therapy when penicillin or amoxicillin can be used. 2, 6 This unnecessarily broadens antibiotic spectrum, increases cost, and promotes resistance. 6

Comparative Efficacy Data

Cefdinir demonstrates superior bacterial eradication compared to penicillin V in clinical trials:

  • Cefdinir: 91-92% eradication rate 3, 4
  • Penicillin V: 77-83% eradication rate 3, 4
  • Clinical cure rates: 94-95% for cefdinir vs. 83-89% for penicillin 3, 4, 5

However, this superior efficacy does not justify using cefdinir as first-line therapy because penicillin/amoxicillin still achieves excellent outcomes with strong, high-quality evidence, and no documented GAS resistance exists anywhere in the world. 1, 2

Important Adverse Effect Profile

Diarrhea occurs more frequently with cefdinir than with penicillin (statistically significant, P < 0.001), though discontinuation rates due to adverse events are generally similar. 3, 7 Patients should be counseled about this expected side effect. 3, 7

Administration Considerations

  • Cefdinir may be taken without regard to food, though high-fat meals reduce absorption by 33-44% in suspension formulations. 8 This reduction is not clinically significant as efficacy studies were conducted without regard to food intake. 8
  • Oral suspension has superior palatability compared to other oral antimicrobials, which may improve adherence in pediatric patients. 9, 7
  • Patients become non-contagious after 24 hours of appropriate antibiotic therapy, but must complete the full 10-day course. 2

Renal Dosing Adjustments

Cefdinir clearance is reduced in renal dysfunction as renal excretion is the predominant elimination pathway. 8 For patients with creatinine clearance <30 mL/min or undergoing hemodialysis, dosage adjustment is required per FDA labeling, though specific GAS pharyngitis dosing in renal impairment is not well-established in guidelines. 8

Common Prescribing Errors to Avoid

  • Do not prescribe cefdinir for patients with immediate penicillin hypersensitivity - use clindamycin or azithromycin instead 2, 6
  • Do not shorten the treatment course below 10 days despite clinical improvement - this increases treatment failure and rheumatic fever risk 1, 2, 6
  • Do not use cefdinir as first-line therapy when penicillin/amoxicillin or first-generation cephalosporins are appropriate 2, 6
  • Do not assume all penicillin-allergic patients need cefdinir - assess allergy type and consider first-generation cephalosporins first 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.